D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 78 Citations 22,255 438 World Ranking 1917 National Ranking 31

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Cancer

Jianming Xu mainly investigates Internal medicine, Cancer research, Soil water, Environmental chemistry and Coactivator. His Internal medicine study integrates concerns from other disciplines, such as Placebo, Endocrinology and Oncology. The Cancer research study combines topics in areas such as Cancer, Metastasis, Mammary tumor, Twist transcription factor and Molecular biology.

His research on Soil water also deals with topics like

  • Microbial population biology, which have a strong connection to Ecology,
  • Nitrogen together with Incubation. Jianming Xu combines subjects such as Soil contamination, Environmental engineering, Pollutant and Pollution with his study of Environmental chemistry. His study focuses on the intersection of Coactivator and fields such as Nuclear receptor with connections in the field of Cell biology.

His most cited work include:

  • Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. (3704 citations)
  • Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial (773 citations)
  • Partial Hormone Resistance in Mice with Disruption of the Steroid Receptor Coactivator-1 (SRC-1) Gene (630 citations)

What are the main themes of his work throughout his whole career to date?

Jianming Xu spends much of his time researching Internal medicine, Soil water, Environmental chemistry, Agronomy and Oncology. His research in Internal medicine intersects with topics in Gastroenterology and Endocrinology. Jianming Xu has included themes like Coactivator, Receptor and Nuclear receptor in his Endocrinology study.

He combines topics linked to Rhizosphere with his work on Soil water. His Environmental chemistry research incorporates elements of Organic matter, Biochar, Sorption and Microbial population biology. His studies examine the connections between Cancer and genetics, as well as such issues in Cancer research, with regards to Metastasis and Nuclear receptor coactivator 3.

He most often published in these fields:

  • Internal medicine (24.97%)
  • Soil water (18.76%)
  • Environmental chemistry (16.79%)

What were the highlights of his more recent work (between 2017-2021)?

  • Environmental chemistry (16.79%)
  • Soil water (18.76%)
  • Internal medicine (24.97%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Environmental chemistry, Soil water, Internal medicine, Biochar and Soil pH. The study incorporates disciplines such as Nitrification, Microbial population biology, Environmental remediation, Denitrification and Amendment in addition to Environmental chemistry. His biological study spans a wide range of topics, including Rhizosphere, Contamination, Agronomy and Pollution.

Jianming Xu has researched Internal medicine in several fields, including Placebo and Oncology. His research combines Phases of clinical research and Oncology. The Biochar study combines topics in areas such as Arsenic, Manure, Cadmium, Straw and Aqueous solution.

Between 2017 and 2021, his most popular works were:

  • Zeolite-supported nanoscale zero-valent iron: New findings on simultaneous adsorption of Cd(II), Pb(II), and As(III) in aqueous solution and soil (192 citations)
  • A review of the identification and detection of heavy metal ions in the environment by voltammetry. (160 citations)
  • Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study. (110 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Enzyme

His main research concerns Environmental chemistry, Soil water, Biochar, Cadmium and Soil pH. His Environmental chemistry study combines topics from a wide range of disciplines, such as Amendment, Soil contamination, Nitrification and Environmental remediation. His work carried out in the field of Soil water brings together such families of science as Agriculture, Agronomy and Abundance.

His Biochar study integrates concerns from other disciplines, such as Soil conditioner, Straw, Bioavailability, Bulk soil and Aqueous solution. His study in Cadmium is interdisciplinary in nature, drawing from both Environmental health, Adsorption, Pollution and Arsenic. As a member of one scientific family, he mostly works in the field of Soil pH, focusing on Phosphorus and, on occasion, Nutrient.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.

Ann Lii Cheng;Yoon Koo Kang;Zhendong Chen;Chao Jung Tsao.
Lancet Oncology (2009)

5361 Citations

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

George D Demetri;Peter Reichardt;Yoon-Koo Kang;Jean-Yves Blay.
The Lancet (2013)

1219 Citations

Partial Hormone Resistance in Mice with Disruption of the Steroid Receptor Coactivator-1 (SRC-1) Gene

Jianming Xu;Yuhong Qiu;Francesco J. DeMayo;Sophia Y. Tsai.
Science (1998)

798 Citations

Activation of PPARγ coactivator-1 through transcription factor docking

Pere Puigserver;Guillaume Adelmant;Zhidan Wu;Melina Fan.
Science (1999)

718 Citations

Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

Jin Li;Shukui Qin;Jianming Xu;Jianping Xiong.
Journal of Clinical Oncology (2016)

692 Citations

An essential heparin-binding domain in the fibroblast growth factor receptor kinase

Mikio Kan;Fen Wang;Jianming Xu;John W. Crabb.
Science (1993)

662 Citations

Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial

Ann Lii Cheng;Yoon Koo Kang;Deng Yn Lin;Joong Won Park.
Journal of Clinical Oncology (2013)

646 Citations

Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions.

Neil J. McKenna;Jianming Xu;Zafar Nawaz;Sophia Y. Tsai.
The Journal of Steroid Biochemistry and Molecular Biology (1999)

621 Citations

The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development

Jianming Xu;Lan Liao;Guang Ning;Hiromi Yoshida-Komiya.
Proceedings of the National Academy of Sciences of the United States of America (2000)

592 Citations

Review of the in vivo functions of the p160 steroid receptor coactivator family.

Jianming Xu;Qingtian Li.
Molecular Endocrinology (2003)

565 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jianming Xu

Bert W. O'Malley

Bert W. O'Malley

Baylor College of Medicine

Publications: 123

Masatoshi Kudo

Masatoshi Kudo

Kindai University

Publications: 123

Ann-Lii Cheng

Ann-Lii Cheng

National Taiwan University

Publications: 90

Jordi Bruix

Jordi Bruix

University of Barcelona

Publications: 61

Yoon-Koo Kang

Yoon-Koo Kang

University of Ulsan

Publications: 58

Kwang Hyub Han

Kwang Hyub Han

Yonsei University

Publications: 56

Andrew X. Zhu

Andrew X. Zhu

Harvard University

Publications: 54

Josep M. Llovet

Josep M. Llovet

Icahn School of Medicine at Mount Sinai

Publications: 51

Hailong Wang

Hailong Wang

Foshan University

Publications: 50

Yakov Kuzyakov

Yakov Kuzyakov

University of Göttingen

Publications: 49

Jörg Rinklebe

Jörg Rinklebe

University of Wuppertal

Publications: 45

Wallace L. McKeehan

Wallace L. McKeehan

Texas A&M Health Science Center

Publications: 44

Francesco J. DeMayo

Francesco J. DeMayo

National Institutes of Health

Publications: 44

Takuji Okusaka

Takuji Okusaka

National Cancer Centre

Publications: 41

Nanthi Bolan

Nanthi Bolan

University of Western Australia

Publications: 40

Jizhong Zhou

Jizhong Zhou

University of Oklahoma

Publications: 40

Something went wrong. Please try again later.